Diagnostic Journey, Patient Experience, and Disparities in the Treatment of Spinal Muscular Atrophy (SMA) in the MedStar Health System

Abroad (travel likely)Recruiting

Conditions

Spinal Muscular Atrophy (SMA)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

MedStar Health Research Institute, Washinton, District of Columbia, United States
Contact: Study coordinator (Gabrielle Edwards, BS) · gabrielle.edwards@medstar.net · 2022219998
Contact: Principal Investigator (Nicholas Streicher, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies

Spinal Muscular Atrophy

Abroad (travel likely)Recruiting

Memphis, United States

A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy

Spinal Muscular Atrophy (SMA)

Abroad (travel likely)RecruitingPHASE2

Little Rock, United States · San Diego, United States

Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy

Spinal Muscular Atrophy · Spine Deformity · Scoliosis

Abroad (travel likely)Recruiting

Phoenix, United States · Orange, United States

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Neuromuscular Diseases (NMD) · Amyotrophic Lateral Sclerosis · Myasthenia Gravis

Abroad (travel likely)Recruiting

Columbia, United States